These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15077144)

  • 21. What have animal models taught us about the p53 pathway?
    Lozano G; Zambetti GP
    J Pathol; 2005 Jan; 205(2):206-20. PubMed ID: 15643668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
    Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C. elegans ced-13 can promote apoptosis and is induced in response to DNA damage.
    Schumacher B; Schertel C; Wittenburg N; Tuck S; Mitani S; Gartner A; Conradt B; Shaham S
    Cell Death Differ; 2005 Feb; 12(2):153-61. PubMed ID: 15605074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of p53 activation--spoilt for choice.
    Vousden KH
    J Cell Sci; 2006 Dec; 119(Pt 24):5015-20. PubMed ID: 17158908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic analysis of the p53 gene in non-melanoma skin cancer and correlation with apoptosis and cell proliferation.
    Stratigos AJ; Kapranos N; Petrakou E; Anastasiadou A; Pagouni A; Christofidou E; Petridis A; Papadopoulos O; Kokka E; Antoniou C; Georgala S; Katsambas AD
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):180-6. PubMed ID: 15752287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction.
    Moll UM; Marchenko N; Zhang XK
    Oncogene; 2006 Aug; 25(34):4725-43. PubMed ID: 16892086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells.
    Song YC; Kim SH; Juhnn YS; Song YS
    Ann N Y Acad Sci; 2007 Jan; 1095():26-34. PubMed ID: 17404014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 and its downstream proteins as molecular targets of cancer.
    Sun Y
    Mol Carcinog; 2006 Jun; 45(6):409-15. PubMed ID: 16652354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stress-induced p53 runs a transcription-independent death program.
    Erster S; Moll UM
    Biochem Biophys Res Commun; 2005 Jun; 331(3):843-50. PubMed ID: 15865940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of p53 in the cancer of the larynx.
    Assimakopoulos D; Kolettas E; Zagorianakou N; Evangelou A; Skevas A; Agnantis NJ
    Anticancer Res; 2000; 20(5B):3555-64. PubMed ID: 11131662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 gene therapy using RNA interference.
    Berindan-Neagoe I; Balacescu O; Burz C; Braicu C; Balacescu L; Tudoran O; Cristea V; Irimie A
    J BUON; 2009 Sep; 14 Suppl 1():S51-9. PubMed ID: 19785070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment.
    Tzatsos A; Papavassiliou AG
    Anticancer Res; 1999; 19(5B):4353-6. PubMed ID: 10628400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of p53 in apoptosis.
    Amaral JD; Xavier JM; Steer CJ; Rodrigues CM
    Discov Med; 2010 Feb; 9(45):145-52. PubMed ID: 20193641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
    French JE
    IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis and cancer mechanisms.
    Pan H; Yin C; Van Dyke T
    Cancer Surv; 1997; 29():305-27. PubMed ID: 9338106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.